Alzheimer's Disease
Genetics Consortium

ADGC Publications

Found 5 results

Filters: Author is Peskind, Elaine [Clear All Filters]

2019

Wheeler JM, McMillan P, Strovas TJ, Liachko NF, Amlie-Wolf A, Kow RL, Klein RL, Szot P, Robinson L, Guthrie C et al.. 2019. Activity of the poly(A) binding protein MSUT2 determines susceptibility to pathological tau in the mammalian brain.. Sci Transl Med. 11(523)

2015

Wang L-S, Naj AC, Graham RR, Crane PK, Kunkle BW, Cruchaga C, Murcia JDGonzalez, Cannon-Albright L, Baldwin CT, Zetterberg H et al.. 2015. Rarity of the Alzheimer disease-protective APP A673T variant in the United States.. JAMA Neurol. 72(2):209-16.

2014

Naj AC, Jun G, Reitz C, Kunkle BW, Perry W, Park YSon, Beecham GW, Rajbhandary RA, Hamilton-Nelson KL, Wang L-S et al.. 2014. Effects of multiple genetic loci on age at onset in late-onset Alzheimer disease: a genome-wide association study.. JAMA Neurol. 71(11):1394-404.

2011

Naj AC, Jun G, Beecham GW, Wang L-S, Vardarajan BNarayan, Buros J, Gallins PJ, Buxbaum JD, Jarvik GP, Crane PK et al.. 2011. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease.. Nat Genet. 43(5):436-41.

Cruchaga C, Kauwe JSK, McKean D, Bailey M, Patty D, Mayo K, Bertlesen S, Hinrichs A, Peskind E, Li G et al.. 2011. Genome-wide association analyses using cerebrospinal fluid tau and phospho-tau and Aβ42 levels as endophenotypes for Alzheimer’s disease. AAIC (ICAD) 2011, Paris, France.